Найдено научных статей и публикаций: 2, для научной тематики: Diffuse toxic goiter
1.
Lutoshkina E.B., Sholomov I.I.
- Saratov Journal of Medical Scientific Research , 2012
Aim of the study: to identify the features of neuropsychological and neuroimaging status in patients with Graves’ disease. Materials and methods. The study is based on the analysis of the results of neurological, neuropsychological and neuroimaging studies in 53 patients with di...
Aim of the study: to identify the features of neuropsychological and neuroimaging status in patients with Graves’ disease. Materials and methods. The study is based on the analysis of the results of neurological, neuropsychological and neuroimaging studies in 53 patients with diffuse toxic goiter with the experience of the disease is not more than 5 years. Results. Found that patients with diffuse toxic goiter in the early stages of the disease there are changes in neu-ropsychological and neuroimaging status, which indicates the feasibility study of this category of patients for a neurologist appointment of appropriate therapy. Conclusion. The study evaluated the neuroimaging and neuropsychological status of patients with Graves’ disease. The goal set in the study achieved.
Lutoshkina E.B., Sholomov I.I. Neuropsychological and neuroimaging status in patients diffuse toxic goiter // Saratov Journal of Medical Scientific Research, Vol. 8, Issue 2, 2012, pp. 488-491
2.
Rodionova T.I., Onyushkina N.Yu.
- Saratov Journal of Medical Scientific Research , 2011
Probability of relapse development of diffuse toxic goiter during the nearest two years after treatment is determined by its results and stressogenic capacity level, which is defined by Holmes and Rage method. As long as satisfactory treatment results and level of stressogenic capacity are above 300...
Probability of relapse development of diffuse toxic goiter during the nearest two years after treatment is determined by its results and stressogenic capacity level, which is defined by Holmes and Rage method. As long as satisfactory treatment results and level of stressogenic capacity are above 300 points, the risk of diffuse toxic goiter relapse run to 68,5%
Rodionova T.I., Onyushkina N.Yu. Stressogenic aspects of diffuse toxic goiter relapse with signs of thyrotoxic myocar-dial dystrophy // Saratov Journal of Medical Scientific Research, Vol. 7, Issue 1, 2011, pp. 174-175